Galmed Pharmaceuticals (GLMD) Prepaid Assets (2024 - 2025)
Galmed Pharmaceuticals (GLMD) recorded quarterly Prepaid Assets of $267000.0 in Q4 2025, down 42.33% quarter-over-quarter from $463000.0 in Q4 2024, and down 42.33% on a YoY basis from $463000.0 in Q4 2024.
Galmed Pharmaceuticals (GLMD) Prepaid Assets (2024 - 2025) Analysis & Trends
Galmed Pharmaceuticals' Prepaid Assets history runs 2 years deep, the most recent figure standing at $267000.0 for Q4 2025.
- In Q4 2025, Prepaid Assets fell 42.33% year-over-year to $267000.0; the TTM figure through Dec 2025 stood at $267000.0 (down 42.33% YoY), while the FY2025 annual figure was $267000.0, down 42.33% from the prior year.
- Prepaid Assets was $267000.0 for Q4 2025 at Galmed Pharmaceuticals, down from $463000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $463000.0 in Q4 2024 to a low of $267000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Galmed Pharmaceuticals | 2.48 Mn | -1.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 267,000.00 |
| Dec 31, 2024 | 463,000.00 |